top of page
ECG changes during haloperidol and pimozide treatment of Tourette's disorder
Fulop, G.; Phillips, R. A.; Shapiro, A. K.; Gomes, J. A.; Shapiro, E.; Nordlie, J. W.
Abstract:
The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.
Automatic Tags
Female; Humans; Male; Adult; Random Allocation; Heart Rate; Heart; Clinical Trials as Topic; Electrocardiography; Placebos; Haloperidol; Pimozide; Tourette Syndrome
bottom of page